# | Title | Journal | Year | Citations |
---|
|
1 | Methylene Blue - a Therapeutic Dye for All Seasons? | Journal of Chemotherapy | 2002 | 324 |
2 | Epidemiology, Clinical Manifestations, and Therapy of Infections Caused by Dematiaceous Fungi | Journal of Chemotherapy | 2003 | 236 |
3 | Azithromycin: 3-Day Versus 5-Day Course in the Treatment of Respiratory Tract Infections in Children | Journal of Chemotherapy | 1997 | 193 |
4 | Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review | Journal of Chemotherapy | 2017 | 183 |
5 | Inhibition of P-Glycoprotein Function and Expression by Kaempferol and Quercetin | Journal of Chemotherapy | 2005 | 175 |
6 | Evolving Resistance Patterns ofStreptococcus pneumoniae:A Link with Long-Acting Macrolide Consumption? | Journal of Chemotherapy | 1999 | 164 |
7 | Trends in the Antimicrobial Susceptibility of Bacterial Respiratory Tract Pathogens - Findings of the Alexander Project 1992-1996 | Journal of Chemotherapy | 1999 | 163 |
8 | The Role of PK/PD Parameters to Avoid Selection and Increase of Resistance: Mutant Prevention Concentration | Journal of Chemotherapy | 2004 | 125 |
9 | In VitroAntimicrobial Activity of Propolis Dry Extract | Journal of Chemotherapy | 2000 | 110 |
10 | Antibiotic Induced Endotoxin Release and Clinical Sepsis: a Review | Journal of Chemotherapy | 2001 | 104 |
11 | From Conventional to Stealth Liposomes: a New Frontier in Cancer Chemotherapy | Journal of Chemotherapy | 2004 | 99 |
12 | Disseminated Aspergillosis in Intensive Care Unit Patients: An Autopsy Study | Journal of Chemotherapy | 2003 | 92 |
13 | The Role ofLactobacillusProbiotics in the Treatment or Prevention of Urogenital Infections – A Systematic Review | Journal of Chemotherapy | 2009 | 90 |
14 | High Dose Ifosfamide in Combination with High Dose Methotrexate, Adriamycin and Cisplatin in the Neoadjuvant Treatment of Extremity Osteosarcoma: Preliminary Results of an Italian Sarcoma Group/Scandinavian Sarcoma Group Pilot Study | Journal of Chemotherapy | 2002 | 89 |
15 | Bactericidal Activity ofPistacia lentiscusMastic Gum AgainstHelicobacter pylori | Journal of Chemotherapy | 2001 | 87 |
16 | Antimicrobial Action and Pharmacokinetics/Pharmacodynamics: The Use of AUIC to Improve Efficacy and Avoid Resistance | Journal of Chemotherapy | 1999 | 86 |
17 | Activity of Plazomicin (ACHN-490) against MDR clinical isolates ofKlebsiella pneumoniae, Escherichia coli, andEnterobacterspp. from Athens, Greece | Journal of Chemotherapy | 2012 | 86 |
18 | Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update | Journal of Chemotherapy | 2017 | 85 |
19 | Induced Resistance in the Human Non Small Cell Lung Carcinoma (NCI-H460) Cell Line In Vitro by Anticancer Drugs | Journal of Chemotherapy | 2006 | 84 |
20 | Zygomycosis in Italy: A Survey of FIMUA-ECMM (Federazione Italiana Di Micopatologia Umana ed Animale and European Confederation of Medical Mycology) | Journal of Chemotherapy | 2009 | 82 |
21 | Effects of Rifaximin Administration on the Intestinal Microbiota in Patients with Ulcerative Colitis | Journal of Chemotherapy | 2002 | 80 |
22 | Neuroendocrine Carcinoma of the Uterine Cervix: A Clinicopathologic Retrospective Study of 31 Cases with Prognostic Implications | Journal of Chemotherapy | 2006 | 78 |
23 | Definition and Classification of Intra-abdominal Infections | Journal of Chemotherapy | 2009 | 78 |
24 | Impact of Antimicrobial Agents on Human Intestinal Microflora | Journal of Chemotherapy | 1990 | 77 |
25 | Immunomodulation by Macrolide Antibiotics | Journal of Chemotherapy | 2001 | 75 |
26 | Carbapenems | Journal of Chemotherapy | 2013 | 75 |
27 | Comparison of the Efficacy and Tolerability of Amoxycillin/Clavulanic Acid 875mg b.i.d. with Cefuroxime 500mg b.i.d. in the Treatment of Chronic and Acute Exacerbation of Chronic Sinusitis in Adults | Journal of Chemotherapy | 2002 | 72 |
28 | SERPINE1 as a cancer-promoting gene in gastric adenocarcinoma: facilitates tumour cell proliferation, migration, and invasion by regulating EMT | Journal of Chemotherapy | 2019 | 72 |
29 | Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria | Journal of Chemotherapy | 2016 | 71 |
30 | In-VitroActivity of Nisin Against Clinical Isolates ofClostridium difficile | Journal of Chemotherapy | 2004 | 70 |
31 | Detection, treatment, and prevention of carbapenemase-producingEnterobacteriaceae: Recommendations from an International Working Group | Journal of Chemotherapy | 2013 | 70 |
32 | The Increase in Carbapenem Use and Emergence ofStenotrophomonas maltophiliaas an Important Nosocomial Pathogen | Journal of Chemotherapy | 1999 | 69 |
33 | Effects of Rifaximin on Bacterial Virulence Mechanisms at Supra- and Sub-Inhibitory Concentrations | Journal of Chemotherapy | 2008 | 67 |
34 | Carbapenem Versus Fosfomycin Tromethanol in the Treatment of Extended-Spectrum Beta-Lactamase-ProducingEscherichia Coli-Related Complicated Lower Urinary Tract Infection | Journal of Chemotherapy | 2010 | 67 |
35 | Antimicrobial stewardship knowledge and perception among physicians and pharmacists at leading tertiary teaching hospitals in Zambia: implications for future policy and practice | Journal of Chemotherapy | 2019 | 66 |
36 | In VitroAntimicrobial Activity ofPistacia lentiscusL. Extracts: Preliminary Report | Journal of Chemotherapy | 1996 | 65 |
37 | In VitroInteraction of Colistin and Rifampin on Multidrug-ResistantPseudomonas aeruginosa | Journal of Chemotherapy | 2003 | 65 |
38 | Microbiological Evaluation of Commercial Probiotic Products Available in the USA in 2009 | Journal of Chemotherapy | 2010 | 65 |
39 | Emergence of Tigecycline and Colistin Resistance inAcinetobacterSpecies Isolated from Patients in Kuwait Hospitals | Journal of Chemotherapy | 2011 | 65 |
40 | Release of Antibiotics from Polymethylmethacrylate Cement | Journal of Chemotherapy | 2002 | 62 |
41 | Microbiological Activity and Clinical Efficacy of a Colistin and Rifampin Combination in Multidrug-ResistantPseudomonas aeruginosaInfections | Journal of Chemotherapy | 2004 | 62 |
42 | ScedosporiumSpecies Infections and Treatments | Journal of Chemotherapy | 2003 | 60 |
43 | Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Tigecycline | Journal of Chemotherapy | 2005 | 60 |
44 | Bevacizumab in Combination with Metronomic Chemotherapy in Patients with Anthracycline- and Taxane-Refractory Breast Cancer | Journal of Chemotherapy | 2008 | 60 |
45 | Probiotics and clinical effects: is the number what counts? | Journal of Chemotherapy | 2013 | 60 |
46 | Paclitaxel-induced pneumonitis in patients with breast cancer: case series and review of the literature | Journal of Chemotherapy | 2017 | 59 |
47 | Immunomodulating Activity of Quinolones: Review | Journal of Chemotherapy | 2002 | 58 |
48 | Brucellosis in the Middle East: A Persistent Medical, Socioeconomic and Political Issue | Journal of Chemotherapy | 2007 | 58 |
49 | In VitroAntifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries | Journal of Chemotherapy | 2009 | 58 |
50 | Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression | Journal of Chemotherapy | 2012 | 58 |